Skip to main
PAYS

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign is a niche player in the rapidly growing industry of prepaid card programs, offering multiple customized payment solutions primarily focused on the pharmaceutical, healthcare, hospitality, and retail sectors. The company's strong 1Q results, with 51% Y/Y growth in total revenue and 113% Y/Y growth in adjusted EBITDA, demonstrate their ability to successfully navigate the market and their potential for continued growth. With initial 2026 guidance above forecasts and continued focus on developing innovative solutions in the pharmaceutical market, PaySign's financial outlook remains positive.

Bears say

PaySign is likely to face significant pressure in the near future due to their high reliance on the pharmaceutical industry for a large portion of their revenue. Furthermore, the company's international expansion opportunities may not prove to be as lucrative as expected, and their focus on developing solutions for specific industries may result in limited growth potential. Additionally, the recent decision to phase out their legacy Pharma Prepaid contracts could significantly impact their top-line growth.

PaySign Inc (PAYS) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 2 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.